Both in Biotechnology
Curis vs Calidi Biotherapeutics
Over the past year CRIS returned −97.5% and CLDI returned −95.6%; their daily moves had a correlation of -0.01.
CRIS −97.5% CLDI −95.6%Growth of $1, one year, split-adjusted
| Metric | CRIS | CLDI |
|---|---|---|
| Price | $0.8290 | $1.08 |
| Market cap | $2.0M | $2.8M |
| Today | −0.29% | +0.93% |
| 1 month | −44.4% | −18.2% |
| 6 months | −91.9% | −71.8% |
| Year to date | −95.8% | −94.2% |
| 1 year | −97.5% | — |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 0.5× | — |
| Net cash | $5.1M | $3.1M |
| Dividend yield | — | — |
| Volatility (60d) | 126.5% | 93.7% |
| Short % of float | 3.7% | 1.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).